You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 19, 2024

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Dorzolamide Hydrochloride And Timolol Maleate patents expire, and what generic alternatives are available?

Dorzolamide Hydrochloride And Timolol Maleate is a drug marketed by Alembic, Bausch And Lomb, Chartwell Molecular, Epic Pharma Llc, Eugia Pharma, Fdc Ltd, Gland Pharma Ltd, Hikma, Indoco, Ingenus Pharms Llc, Micro Labs, Rubicon, Sandoz, Somerset, Teva Pharms, and Zambon Spa. and is included in nineteen NDAs.

The generic ingredient in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is dorzolamide hydrochloride; timolol maleate. There are fifteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dorzolamide Hydrochloride And Timolol Maleate

A generic version of DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE was approved as dorzolamide hydrochloride; timolol maleate by SANDOZ on November 6th, 2008.

  Sign Up

Summary for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Drug patent expirations by year for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Recent Clinical Trials for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of FloridaPhase 1
AllerganPhase 3
Meir Medical CenterN/A

See all DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE clinical trials

Pharmacology for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

US Patents and Regulatory Information for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 213099-001 May 4, 2021 AT1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 078704-001 Sep 28, 2009 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fdc Ltd DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 205295-001 Jun 13, 2019 AT1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Epic Pharma Llc DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 203058-001 Sep 22, 2014 AT1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Micro Labs DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 204777-001 May 28, 2020 AT1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland Pharma Ltd DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 215520-001 Sep 19, 2022 AT1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.